The world’s first contraceptive injection for men could be available for consumer use within six months after Indian scientists announced that clinical trials have been completed on the drug. The contraceptive, which remains effective for 13 years before it loses potency, has been sent to the national Drug Controller General of India for final approval. It contains a polymer called Steryene Maleic Anhydride developed in the 1970s that inhibits sperm production. If approved, the injection will be the first male contraceptive offered to consumers in the world, although it will be marketed as a long-term alternative to a vasectomy, rather than a short-term option like the implant or coil that are on offer to women. However rigorous testing means it won’t be available for another six months, minimum.
Delayed A week…More Details